Akero Therapeutics

Akero Therapeutics

Biotechnology, 601 Gateway BLVD Ste 350, South San Francisco, California, 94080, United States, 11-50 Employees

akerotx.com

  • twitter
  • LinkedIn

phone no Phone Number: 65********

Who is AKERO THERAPEUTICS

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. ...

Read More

map
  • 601 Gateway BLVD Ste 350, South San Francisco, California, 94080, United States Headquarters: 601 Gateway BLVD Ste 350, South San Francisco, California, 94080, United States
  • 2017 Date Founded: 2017
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from AKERO THERAPEUTICS

Akero Therapeutics Org Chart and Mapping

Employees

Dominick Villani

Vice President of Quality Assurance

Christopher Ayscue-Tse

Associate Director, Regulatory Affairs

Kitty Yale

EVP and Chief Development Officer

Reshma Shringarpure

Vice President, Clinical Research and Medical Affairs

Libette Luce

Vice President, Head of Regulatory Affairs

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Akero Therapeutics

Answer: Akero Therapeutics's headquarters are located at 601 Gateway BLVD Ste 350, South San Francisco, California, 94080, United States

Answer: Akero Therapeutics's phone number is 65********

Answer: Akero Therapeutics's official website is https://akerotx.com

Answer: Akero Therapeutics's revenue is $1 Million to $5 Million

Answer: Akero Therapeutics's SIC: 2834

Answer: Akero Therapeutics's NAICS: 325412

Answer: Akero Therapeutics has 11-50 employees

Answer: Akero Therapeutics is in Biotechnology

Answer: Akero Therapeutics contact info: Phone number: 65******** Website: https://akerotx.com

Answer: Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH. Akero is headquartered in South San Francisco.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access